Biocryst Pharmaceuticals (BCRX) Operating Margin Growth (3y) (2013 - 2026)
Biocryst Pharmaceuticals (BCRX) Operating Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 1,129.00 |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 2.00 |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 59.00 |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | -1,031.00 |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | -925.00 |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | -46.00 |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 6,666.00 |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Biocryst Pharmaceuticals | 2.47 Bn | 2.12 Bn | 214.41 Mn | 7,021.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7,021.00 |
| Mar 31, 2026 | -40,724.00 |
| Dec 31, 2025 | 3.68 Mn |
| Sep 30, 2025 | 4,157.00 |
| Jun 30, 2025 | 7,122.00 |
| Mar 31, 2025 | 11,465.00 |
| Dec 31, 2024 | 10,722.00 |
| Sep 30, 2024 | 11,533.00 |
| Jun 30, 2024 | 6,723.00 |
| Mar 31, 2024 | 25,395.00 |
| Dec 31, 2023 | 125,922.00 |
| Sep 30, 2023 | 68,872.00 |
| Jun 30, 2023 | 131,625.00 |
| Mar 31, 2023 | 80,832.00 |
| Dec 31, 2022 | -5,795.00 |
| Sep 30, 2022 | 195,435.00 |
| Jun 30, 2022 | 235,848.00 |
| Mar 31, 2022 | 39,815.00 |
| Dec 31, 2021 | 81,504.00 |
| Sep 30, 2021 | 185,087.00 |